连续57例急性A型主动脉夹层患者采用Ascyrus Medical Dissection Stent治疗的临床结局
该研究回顾性纳入德国2个主动脉中心2020至2022年间连续57例接受Ascyrus Medical Dissection Stent(AMDS)治疗的急性A型主动脉夹层(AADA)患者,实际院内死亡率为16%,低于德国AADA登记评分预测的22%;术后新发AMDS相关并发症(中央支架塌陷)发生率为9%(n=5),完全性中央塌陷未影响30天死亡率。
要点
- 57例AADA患者接受AMDS治疗,实际院内死亡率16%,低于德国AADA登记评分预测的22%。
- 术后并发症包括急性肾功能不全37%、需临时透析16%、永久透析5%、谵妄26%、因出血再探查14%、气管切开14%、新发卒中4%。
- 术后CT和胸部X线发现新发AMDS相关并发症(中央支架塌陷)9%(n=5),完全性中央塌陷未影响30天死亡率。
核心结论
- AMDS可成功用于AADA,30天死亡率与德国AADA登记评分预测相符,处于可接受水平。
- 作者强烈推荐术前仔细评估患者个体主动脉解剖以识别潜在禁忌证,并正确置入器械,以避免完全性中央AMDS塌陷。
研究设计与样本
- 回顾性研究,数据来自德国2个主动脉中心2020至2022年收治的所有AADA患者,纳入全部接受AMDS治疗者,共57例。
主要发现
- 平均年龄64.6±10.8岁,男性59.7%(n=34)。
- 实际院内死亡率为16%,低于德国AADA登记评分预测的22%。
- 中位ICU住院时间5天(四分位距3-13),中位住院时间12天(四分位距10-22)。
- 术后并发症包括急性肾功能不全37%、需临时透析16%、需永久透析5%、谵妄26%、因出血再探查14%、气管切开14%、新发卒中4%。
- 术后CT和胸部X线发现新发AMDS相关并发症(中央支架塌陷)9%(n=5),完全性中央AMDS塌陷的发生率未影响30天死亡率。
临床怎么用
- 作者强烈推荐术前仔细评估患者个体主动脉解剖以识别潜在禁忌证,并正确置入器械,以避免完全性中央AMDS塌陷。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The Ascyrus Medical Dissection Stent (AMDS) has been recently introduced as an alternative for total arch replacement in acute aortic dissection type A (AADA). The aim of this study was to evaluate the postoperative outcomes after AMDS treatment in a large contemporary cohort of AADA patients. METHODS: Data acquisition was performed retrospectively at 2 German aortic centres between 2020 and 2022 and comprised the perioperative parameters and postoperative results of all AADA patients. All patients treated with the AMDS for AADA were included in the study. The primary end point was in-hospital mortality. Secondary end points were defined as early postoperative and AMDS-related complications. RESULTS: Fifty-seven AADA patients treated by AMDS were included in the study group. The mean age was 64.6 ± 10.8 years and 59.7% (n = 34) were males. The actual in-hospital mortality was considerably lower than the predicted mortality risk by the German registry for acute aortic dissection type A score (16% vs 22%). The median ICU and in-hospital stay were 5 (interquartile range: 3-13) and 12 (interquartile range: 10-22) days, respectively. Postoperative complications comprised acute renal insufficiency (37%) with need for temporary (16%) or permanent dialysis (5%), delirium (26%), re-exploration for bleeding (14%), tracheostomy (14%) and new stroke (4%). A new AMDS-related complication (central stent collapse) was observed in 9% (n = 5) by postoperative computed tomography and chest X-ray. The incidence of complete central AMDS collapse did not impact 30-day mortality. CONCLUSIONS: The AMDS may be successfully used in AADA with acceptable 30-day mortality in accordance with the German registry for acute aortic dissection type A score. However, careful preoperative evaluation of the patient's individual aortic anatomy regarding potential contraindications and proper device implantation are strongly recommended to avoid complete central AMDS collapse.
引用
- Luehr M, Gaisendrees C, Yilmaz AK, et al. Treatment of acute type A aortic dissection with the Ascyrus Medical Dissection Stent in a consecutive series of 57 cases. Eur J Cardiothorac Surg. 2023. PMID: 36548434. doi:10.1093/ejcts/ezac581
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。